Leukemia, Acute Lymphoblastic Clinical Trial
Official title:
Phase 2 Study of CD19-directed Chimeric Antigen Receptor-modified T Cells (CART19) for Adult Patients With Minimal Residual Disease During Upfront Treatment for Acute Lymphoblastic Leukemia
This is a single center, single arm, open-label phase 2 study to determine the efficacy of autologous T cells expressing CD19 chimeric antigen receptors expressing tandem TCRζ and 4-1BB (TCRζ/4-1BB) co-stimulatory domains (referred to as "CART19" cells) in adults with minimal residual disease (MRD) during upfront treatment for CD19+ acute lymphoblastic leukemia.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Unknown status |
NCT02360930 -
Vincristine PK and PD in the AYA Population Compared to Younger Children
|
N/A | |
Recruiting |
NCT05306301 -
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
|
Phase 2 | |
Not yet recruiting |
NCT06101381 -
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05440409 -
CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL
|
||
Completed |
NCT02393859 -
Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
|
Phase 3 | |
Completed |
NCT05064787 -
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
|
N/A | |
Terminated |
NCT02435550 -
iCare for Cancer Patients
|
N/A | |
Completed |
NCT02799147 -
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
|
Phase 1/Phase 2 | |
Terminated |
NCT02580981 -
Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses
|
N/A | |
Recruiting |
NCT04307576 -
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
|
Phase 3 | |
Completed |
NCT04942730 -
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
|
Phase 2 | |
Terminated |
NCT01761682 -
Acute Lymphoblastic Leukemia Registry at Asan Medical Center
|
||
Completed |
NCT04327037 -
Safety of Expanded Haploidentical Natural Killer Cells for Leukemia
|
Phase 1 | |
Terminated |
NCT02349178 -
Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT
|
Phase 2 | |
Recruiting |
NCT04209244 -
Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia
|
N/A | |
Recruiting |
NCT03911128 -
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
|
||
No longer available |
NCT00590915 -
Erwinase Master Treatment Protocol
|
N/A |